Hipra Is A Biopharmaceutical Multinational Company Based In Amercataloniaspainspecializing In Preventive Healthcare Through Biologics For Both Animal And Human Healthfounded In 1971Hipra Has Expanded Its Operations Globallywith Subsidiaries In 40 Countriesthree R&D Centersand Six Production Plants In Europe And The Americasthe Company Distributes Its Products In Over 100 Countries Across All Five Continents In The Animal Health Sectorhipra Offers Vaccines For Livestockpoultryand Aquaculturealong With Diagnostic Tools For Monitoring Animal Healthin Human Healththe Company Developed A Recombinant Protein Based Covid 19 Vaccine And Has Expanded Into Digestive Disease Diagnostics Through Its Acquisition Of Goodgut In 2021Hipra Focuses On Preventionhaving Transitioned To This Model In 2009And Aims To Innovate In Immunotherapy And Precision Medicine Within Its Human Health Division
